PCN3- COST ANALYSIS OF SCHIZOPHRENIA TREATMENT IN GERMANY- A COMPARISON OF OLANZAPINE, RISPERIDONE, AND HALOPERIDOL USING A CLINICAL DECISION MODEL

Sep 1, 1999, 00:00
10.1016/S1098-3015(10)75843-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)75843-5/fulltext
Title : PCN3- COST ANALYSIS OF SCHIZOPHRENIA TREATMENT IN GERMANY- A COMPARISON OF OLANZAPINE, RISPERIDONE, AND HALOPERIDOL USING A CLINICAL DECISION MODEL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75843-5&doi=10.1016/S1098-3015(10)75843-5
First page :
Section Title :
Open access? : No
Section Order : 89
Categories :
Tags :
Regions :
ViH Article Tags :